Adverse events prompt FDA warning against lidocaine for teething infants

06/26/2014 | Reuters · HealthDay News

Prescription oral viscous lidocaine 2% solution should not be used to relieve teething pain in infants and toddlers because it can lead to serious injuries, even death, FDA officials warned. The warning was issued after the agency received 22 reports so far this year of serious adverse reactions to the pain medication, including deaths.

View Full Article in:

Reuters · HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX